Filing Details

Accession Number:
0001140361-17-033123
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-23 19:33:33
Reporting Period:
2017-08-21
Accepted Time:
2017-08-23 18:33:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579310 T. Keith Flaherty C/O Loxo Oncology, Inc.
281 Tresser Blvd, 9Th Floor
Stamford CT 06901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-21 3,800 $71.91 20,432 No 4 S Direct
Common Stock Disposition 2017-08-21 3,450 $72.65 16,982 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 13, 2016.
  2. Represents the aggregate of sales effected on the same day at different prices.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $71.32 to $72.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $72.325 to $73.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.